Osteonecrosis of the jaw associated with bevacizumab in treatment: A case series using the FDA Adverse Event Reporting System (FAERS) database

Hardeep S Ahdi; Thomas A Wichelmann; Sasirekha Pandravada; Eli Ehrenpreis; null Advocate Gastroenterology Faculty - Lutheran General; null Advocate Internal Medicine Residents - Lutheran General; Eli Ehrenpreis

doi:10.14309/01.ajg.0000857304.82748.c1

Osteonecrosis of the jaw associated with bevacizumab in treatment: A case series using the FDA Adverse Event Reporting System (FAERS) database

Hardeep S Ahdi, Thomas A Wichelmann, Sasirekha Pandravada, Eli Ehrenpreis, Advocate Gastroenterology Faculty - Lutheran General, Advocate Internal Medicine Residents - Lutheran General, Eli Ehrenpreis

Advocate Aurora Health

Research output: Contribution to journal › Meeting abstract

Original language	American English
Journal	American Journal of Gastroenterology
DOIs	https://doi.org/10.14309/01.ajg.0000857304.82748.c1
Status	Published - Oct 1 2022

Keywords

Osteonecrosis of the jaw
ONJ
Gastroenterology
bevacizumab
Adverse drug reaction

Access to Document

10.14309/01.ajg.0000857304.82748.c1License: Unspecified

https://libkey.io/libraries/1712/10.14309/01.ajg.0000857304.82748.c1

Cite this

Ahdi, H. S., Wichelmann, T. A., Pandravada, S., Ehrenpreis, E., Advocate Gastroenterology Faculty - Lutheran General, Advocate Internal Medicine Residents - Lutheran General, & Ehrenpreis, E. (2022). Osteonecrosis of the jaw associated with bevacizumab in treatment: A case series using the FDA Adverse Event Reporting System (FAERS) database. American Journal of Gastroenterology. https://doi.org/10.14309/01.ajg.0000857304.82748.c1

Ahdi, HS, Wichelmann, TA, Pandravada, S, Ehrenpreis, E, Advocate Gastroenterology Faculty - Lutheran General, Advocate Internal Medicine Residents - Lutheran General & Ehrenpreis, E 2022, 'Osteonecrosis of the jaw associated with bevacizumab in treatment: A case series using the FDA Adverse Event Reporting System (FAERS) database', American Journal of Gastroenterology. https://doi.org/10.14309/01.ajg.0000857304.82748.c1

Ahdi HS, Wichelmann TA, Pandravada S, Ehrenpreis E, Advocate Gastroenterology Faculty - Lutheran General, Advocate Internal Medicine Residents - Lutheran General et al. Osteonecrosis of the jaw associated with bevacizumab in treatment: A case series using the FDA Adverse Event Reporting System (FAERS) database. American Journal of Gastroenterology. 2022 Oct 1. doi: 10.14309/01.ajg.0000857304.82748.c1

@article{b534e408ad0f4f2283177e3315987407,

title = "Osteonecrosis of the jaw associated with bevacizumab in treatment: A case series using the FDA Adverse Event Reporting System (FAERS) database",

keywords = "Osteonecrosis of the jaw, ONJ, Gastroenterology, bevacizumab, Adverse drug reaction",

author = "Ahdi, {Hardeep S} and Wichelmann, {Thomas A} and Sasirekha Pandravada and Eli Ehrenpreis and {Advocate Gastroenterology Faculty - Lutheran General} and {Advocate Internal Medicine Residents - Lutheran General} and Eli Ehrenpreis",

note = "Ahdi H, Wichelmann T, Pandravada S, Ehrenpreis E. S166 Osteonecrosis of the Jaw Associated With Bevacizumab in Treatment: A Case Series Using the FDA Adverse Event Reporting System (FAERS) Database. The American Journal of Gastroenterology. 2022; 117 (10S): e119-e119. doi: 10.14309/01.ajg.0000857304.82748.c1.",

year = "2022",

month = oct,

day = "1",

doi = "10.14309/01.ajg.0000857304.82748.c1",

language = "American English",

journal = "American Journal of Gastroenterology",

}

TY - JOUR

T1 - Osteonecrosis of the jaw associated with bevacizumab in treatment: A case series using the FDA Adverse Event Reporting System (FAERS) database

AU - Ahdi, Hardeep S

AU - Wichelmann, Thomas A

AU - Pandravada, Sasirekha

AU - Ehrenpreis, Eli

AU - Advocate Gastroenterology Faculty - Lutheran General, null

AU - Advocate Internal Medicine Residents - Lutheran General, null

AU - Ehrenpreis, Eli

N1 - Ahdi H, Wichelmann T, Pandravada S, Ehrenpreis E. S166 Osteonecrosis of the Jaw Associated With Bevacizumab in Treatment: A Case Series Using the FDA Adverse Event Reporting System (FAERS) Database. The American Journal of Gastroenterology. 2022; 117 (10S): e119-e119. doi: 10.14309/01.ajg.0000857304.82748.c1.

PY - 2022/10/1

Y1 - 2022/10/1

KW - Osteonecrosis of the jaw

KW - ONJ

KW - Gastroenterology

KW - bevacizumab

KW - Adverse drug reaction

UR - https://institutionalrepository.aah.org/advocategme/239

UR - https://libkey.io/libraries/1712/10.14309/01.ajg.0000857304.82748.c1

U2 - 10.14309/01.ajg.0000857304.82748.c1

DO - 10.14309/01.ajg.0000857304.82748.c1

M3 - Meeting abstract

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

ER -

Osteonecrosis of the jaw associated with bevacizumab in treatment: A case series using the FDA Adverse Event Reporting System (FAERS) database

Keywords

Access to Document

Other files and links

Cite this